Literature DB >> 36224657

Retraction Note to: A stepwise-targeting strategy for the treatment of cerebral ischemic stroke.

Jingbo Hu1, Xueying Tan2, Dongwei Wang3, Yixuan Li3, Hongze Liang3, Jiejun Peng4, Fengyan Li2, Quan Zhou5, Peiwu Geng5, Shuanghu Wang5, Yue Yu6, Jin Liu7.   

Abstract

Entities:  

Year:  2022        PMID: 36224657      PMCID: PMC9554990          DOI: 10.1186/s12951-022-01645-w

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   9.429


× No keyword cloud information.

Retraction to: Journal of Nanobiotechnology (2021) 19:371 10.1186/s12951-021-01118-6

The Editors-in-Chief have retracted this article. After publication, the following concerns were raised: in Fig. 3, the Heart/Saline panel and Heart/Micelle panels partially overlap, respectively, with the Heart/HA-CUR panel and Heart/CUR panel in Fig. S2 in [1]; in Fig. 3, the Heart/Saline and Heart/Micelles panels partially overlap, respectively, with Heart/DEX-SS-IND and Heart/Saline panel in Fig. 7 in [2]; in Fig. 4a, the TGN/cy3 micelles panel in 2.0 h line overlaps with the SA-DEX-CUR panel in the e-Selectin line in Fig. 4 in [3]; in Fig. 5D, panels H2O2 and H2O2 + TPP-MLT overlap, respectively, with panels PTX and FA@PPMoV@PTX in Fig. 4B in [4]. Following these concerns author Jingbo Hu contacted the journal requesting a retraction. They did not respond to the editor's request to share original data. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article. Jingbo Hu agrees to this retraction. The other authors have not responded to any correspondence from the editor/publisher about this retraction.
  4 in total

1.  CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage.

Authors:  Jing-Bo Hu; Shu-Juan Li; Xu-Qi Kang; Jing Qi; Jia-Hui Wu; Xiao-Juan Wang; Xiao-Ling Xu; Xiao-Ying Ying; Sai-Ping Jiang; Jian You; Yong-Zhong Du
Journal:  Carbohydr Polym       Date:  2018-04-03       Impact factor: 9.381

2.  An E-selectin targeting and MMP-2-responsive dextran-curcumin polymeric prodrug for targeted therapy of acute kidney injury.

Authors:  Jing-Bo Hu; Di Liu; Jing Qi; Kong-Jun Lu; Fei-Yang Jin; Xiao-Ying Ying; Jian You; Yong-Zhong Du
Journal:  Biomater Sci       Date:  2018-11-20       Impact factor: 6.843

3.  Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.

Authors:  Shuanghu Wang; Xueying Tan; Shujuan Li; Yunfang Zhou; Peiwu Geng; Ailian Hua; Aiping Deng; Zhihong Yu
Journal:  Oncotarget       Date:  2017-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.